Other
The Breast Adjuvant Study Team
Total Trials
1
Recruiting
0
Active
1
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 1 trials
Late-Stage Pipeline
100%
1 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed trials have results
Key Signals
1 with results
Enrollment Performance
Analytics
Phase 3
1(100.0%)
1Total
Phase 3(1)
Activity Timeline
Global Presence
Loading network data...